+Compare
BJDX
Stock ticker: NASDAQ
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
5.89M

BJDX Bluejay Diagnostics Forecast, Technical & Fundamental Analysis

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
a Summary for BJDX with price predictions
08:00 PM EDT Sep 20, 2023

BJDX in downward trend: price dove below 50-day moving average on August 30, 2023

BJDX moved below its 50-day moving average on August 30, 2023 date and that indicates a change from an upward trend to a downward trend. In of 13 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day moving average for BJDX crossed bearishly below the 50-day moving average on September 06, 2023. This indicates that the trend has shifted lower and could be considered a sell signal. In of 7 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BJDX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for BJDX entered a downward trend on September 21, 2023. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where BJDX's RSI Oscillator exited the oversold zone, of 20 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 34 cases where BJDX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on September 20, 2023. You may want to consider a long position or call options on BJDX as a result. In of 36 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for BJDX just turned positive on September 21, 2023. Looking at past instances where BJDX's MACD turned positive, the stock continued to rise in of 14 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BJDX advanced for three days, in of 72 cases, the price rose further within the following month. The odds of a continued upward trend are .

BJDX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.923) is normal, around the industry mean (24.980). P/E Ratio (0.000) is within average values for comparable stocks, (80.233). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (6.278). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (31.348) is also within normal values, averaging (58.283).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BJDX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BJDX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Medtronic plc (NYSE:MDT), Intuitive Surgical (NASDAQ:ISRG), Boston Scientific Corp (NYSE:BSX), Edwards Lifesciences Corp (NYSE:EW), IQVIA Holdings (NYSE:IQV), Align Technology (NASDAQ:ALGN), Illumina (NASDAQ:ILMN), Exact Sciences Corp (NASDAQ:EXAS), Guardant Health (NASDAQ:GH).

Industry description

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

Market Cap

The average market capitalization across the Medical Specialties Industry is 6.39B. The market cap for tickers in the group ranges from 27 to 3.82T. MKYSF holds the highest valuation in this group at 3.82T. The lowest valued company is FOGCF at 27.

High and low price notable news

The average weekly price growth across all stocks in the Medical Specialties Industry was 0%. For the same Industry, the average monthly price growth was -3%, and the average quarterly price growth was -5%. AVGR experienced the highest price growth at 155%, while HSCS experienced the biggest fall at -52%.

Volume

The average weekly volume growth across all stocks in the Medical Specialties Industry was 25%. For the same stocks of the Industry, the average monthly volume growth was -12% and the average quarterly volume growth was 51%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 71
Price Growth Rating: 66
SMR Rating: 83
Profit Risk Rating: 88
Seasonality Score: -22 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I. Advisor
published Earnings

BJDX is expected to report earnings to fall 33.33% to -7 cents per share on July 25

Bluejay Diagnostics BJDX Stock Earnings Reports
Q2'23
Est.
$-0.08
Q1'23
Missed
by $0.06
Q4'22
Missed
by $0.15
Q3'22
Missed
by $0.07
Q2'22
Missed
by $0.02
The last earnings report on May 10 showed earnings per share of -11 cents, missing the estimate of -5 cents. With 192.84K shares outstanding, the current market capitalization sits at 5.89M.
A.I. Advisor
published General Information

General Information

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
360 Massachusetts Avenue
Phone
+1 844 327-7078
Employees
16
Web
https://www.bluejaydx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
COTY12.270.29
+2.42%
COTY
NEXI0.21N/A
-0.52%
NexImmune
RAMP29.85-0.46
-1.52%
LiveRamp Holdings
DM1.47-0.07
-4.55%
Desktop Metal
BNR0.94-0.07
-6.50%
Burning Rock Biotech Limited

BJDX and

Correlation & Price change

A.I.dvisor tells us that BJDX and OPGN have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BJDX and OPGN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BJDX
1D Price
Change %
BJDX100%
-0.84%
OPGN - BJDX
25%
Poorly correlated
-7.29%
MBOT - BJDX
23%
Poorly correlated
-1.79%
PSNL - BJDX
23%
Poorly correlated
-3.79%
ASXC - BJDX
23%
Poorly correlated
-4.28%
RDNT - BJDX
22%
Poorly correlated
-2.71%
More

Groups containing BJDX

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BJDX
1D Price
Change %
BJDX100%
-0.84%
Medical Specialties
(undefined stocks)
6%
Poorly correlated
+3.67%
Medical Specialties
(undefined stocks)
6%
Poorly correlated
+3.67%